Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The neuronal nicotinic acetylcholine receptor α2β2 subtype is a pentameric ligand-gated ion channel, belonging to the Cys-loop receptor superfamily, formed by the co-assembly of α2 and β2 subunits (typically as heteropentamers)[1][2]. It mediates fast synaptic transmission by forming a cation-selective pore that opens upon binding the neurotransmitter acetylcholine, as well as exogenous ligands such as nicotine[1][2]. This subtype is predominantly expressed in certain regions of the brain and is involved in the modulation of neuronal excitability and neurotransmitter release[1][2]. It contributes to central processes including reward, cognition, and sensory processing, and has been implicated in neurodegenerative and neuropsychiatric disorders, as well as nicotine addiction[2][4]. Different subunit compositions result in diverse pharmacological and physiological properties; the α2β2 subtype, like other β2-containing nAChRs, is high-affinity for nicotine and shows unique sensitivity to other agonists and modulators[2].
Allosteric ligand-gated ion channel activation (agonists bind and open cation channel); Channel desensitization (prolonged agonist exposure induces receptor desensitization); Modulation by positive/negative allosteric modulators
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuronal nicotinic acetylcholine receptor α2β2 subtype (nAChR α2β2).